Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 2 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Recs

0
Player Avatar redskins66 (< 20) Submitted: 3/24/2010 10:26:21 AM : Outperform Start Price: $4.83 CYTX Score: -67.67

cause fools say it won't

Featured Broker Partners


Advertisement